PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.36%
Revenue growth 1.25-1.5x ADI's 7.12%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
15.92%
Gross profit growth above 1.5x ADI's 8.48%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
75.90%
EBIT growth above 1.5x ADI's 11.91%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
75.90%
Operating income growth above 1.5x ADI's 11.91%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
14.77%
Net income growth 1.25-1.5x ADI's 11.49%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
-15.38%
Negative EPS growth while ADI is at 9.09%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-16.00%
Negative diluted EPS growth while ADI is at 4.76%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
50.74%
Share count expansion well above ADI's 1.65%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
51.98%
Diluted share count expanding well above ADI's 2.27%. Michael Burry would fear significant dilution to existing owners' stakes.
-35.45%
Dividend reduction while ADI stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
109.22%
Positive OCF growth while ADI is negative. John Neff would see this as a clear operational advantage vs. the competitor.
186.64%
Positive FCF growth while ADI is negative. John Neff would see a strong competitive edge in net cash generation.
-48.19%
Negative 10Y revenue/share CAGR while ADI stands at 155.76%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
21.71%
5Y revenue/share CAGR under 50% of ADI's 75.95%. Michael Burry would suspect a significant competitive gap or product weakness.
-38.73%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
36.94%
10Y OCF/share CAGR under 50% of ADI's 137.56%. Michael Burry would worry about a persistent underperformance in cash creation.
120.38%
5Y OCF/share CAGR at 50-75% of ADI's 226.67%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
8.97%
Positive 3Y OCF/share CAGR while ADI is negative. John Neff might see a big short-term edge in operational efficiency.
71.28%
Below 50% of ADI's 412.65%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
137.70%
Below 50% of ADI's 495.34%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-45.79%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
127.57%
Below 50% of ADI's 525.01%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
59.18%
Below 50% of ADI's 149.95%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-36.96%
Negative 3Y equity/share growth while ADI is at 36.99%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-5.96%
Cut dividends over 10 years while ADI stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-4.47%
Negative 5Y dividend/share CAGR while ADI stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-34.92%
Negative near-term dividend growth while ADI invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-4.66%
Firm’s AR is declining while ADI shows 13.76%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-1.11%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
2.81%
Positive asset growth while ADI is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-31.13%
We have a declining book value while ADI shows 2.25%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-0.48%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-4.27%
Our R&D shrinks while ADI invests at 0.66%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-1.60%
We cut SG&A while ADI invests at 3.92%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.